Search Results

You are looking at 181 - 190 of 530 items for :

  • "pathology" x
  • Refine by Access: All x
Clear All
Full access

Brady L. Stein, Susan O’Brien, Peter Greenberg, and Ruben A. Mesa

Pathology . J Mol Diagn 2006 ; 8 : 412 – 419 . 12. Maxson JE Gotlib J Pollyea DA . Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML . N Engl J Med 2013 ; 368 : 1781 – 1790 . 13. Piazza R Valletta S

Full access

David R. Braxton

picture of the molecular landscapes of cancer and many insights into the molecular pathology of cancers are accruing. Genomic databases such as cBioPortal ( www.cbiopartal.org ) 8 are providing access to large-scale genomic data where inferences can be

Full access

Brian Vicuna and Al B. Benson III

: 65 – 69 . 15. Morris E Maughan NJ Forman D Quirke P . Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? – The need for high quality pathology . Gut 2007 ; 56 : 1419 – 1425 . 16. Soreide K Janssen EA

Full access

Gregory P. Kalemkerian

only medical and radiation oncology, but also thoracic surgery, pathology, and diagnostic radiology. Another substantial improvement in the NCCN Guidelines for SCLC (and many others) has been the inclusion of “Principles of” sections that provide

Full access

Badar M. Mian

biopsies in a population-based screening study: the impact of borderline lesions . Cancer 1999 ; 85 : 145 – 152 . 35 Orozco R O'Dowd G Kunnel B . Observations on pathology trends in 62,537 prostate biopsies obtained from urology private

Full access

Lori J. Goldstein, Bonnie J. Miller, Nancy Nicotera, and Delinda Pendleton

hand-offs that occur during the intake and registration processes; obtaining patient materials (pathology tissue, radiology films) with complete interpretation in advance of the patient’s first visit; and wherever possible, performance of studies in

Full access

Henry Soo-Min Park

radiation oncology, medical oncology, pathology, radiology, and internal medicine subspecialties, potentially influencing overall survival in a manner that is independent of the institution’s case volume of the particular surgery of interest. Even if we

Full access

Grant A. McArthur

. Chromogenic in situ hybridization and FISH in pathology . Methods Mol Biol 2002 ; 204 : 343 – 351 . 8. Haycox CL Odland PB Olbricht SM Piepkorn M . Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical

Full access

Jonathan R. Strosberg, Gary D. Hammer, and Gerard M. Doherty

Edited by Kerrin G. Robinson

revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors . Am J Surg Pathol 2002 ; 26 : 1612 – 1619 . 34 DeLellis RA Lloyd RV Heitz PU Eng C , eds. World Health Organization Classification of Tumours: Pathology

Full access

Kilian E. Salerno

Neoadjuvant Treatment Following neoadjuvant chemotherapy, indications for RT should be guided by maximal disease stage from either prechemotherapy tumor characteristics at diagnosis or postchemotherapy pathology results. Patients with residual nodal disease